RxSight shareholders re-elect three Class I directors, approve say-on-pay and auditor

RxSight, Inc.

Quorum of ~79.2% (32.18M of 40.62M shares represented) at June 3 annual meeting.
Ron Kurtz, J. Andy Corley, and Juliet Tammenoms Bakker re-elected as Class I directors.
Say-on-pay advisory vote passed with 22.37M for, 3.32M against, 98.7K abstain.
Ratification of Ernst & Young as auditor for FY2025 approved with 31.95M for, 92K against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.